Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for Abivax (ABVX) over the last 4 years, with Q3 2025 value amounting to $38.3 million.

  • Abivax's Non-Current Assets changed N/A to $38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.3 million, marking a year-over-year change of. This contributed to the annual value of $36.9 million for FY2024, which is 1691.71% down from last year.
  • As of Q3 2025, Abivax's Non-Current Assets stood at $38.3 million.
  • Abivax's Non-Current Assets' 5-year high stood at $44.7 million during Q2 2024, with a 5-year trough of $36.1 million in Q1 2025.
  • Moreover, its 4-year median value for Non-Current Assets was $38.3 million (2025), whereas its average is $39.8 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 1008.56% in 2023, then crashed by 1647.09% in 2024.
  • Quarter analysis of 4 years shows Abivax's Non-Current Assets stood at $40.2 million in 2022, then rose by 10.09% to $44.2 million in 2023, then decreased by 16.47% to $36.9 million in 2024, then increased by 3.7% to $38.3 million in 2025.
  • Its Non-Current Assets stands at $38.3 million for Q3 2025, versus $38.0 million for Q2 2025 and $36.1 million for Q1 2025.